Back to search

Finland· FI-REL-REL4813

Mivacron Cum Conservans

A mivacurium chloride product, registered in Finland by The Wellcome Foundation Limited. The same ATC class is registered in 8 of our 19 countries.

ATC M03AC10

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedMivacron Cum ConservansATCM03AC10REGISTER NO.FI-REL-REL4813PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Mivacurium chloride is registered in 8 of 19 countries.

Countries holding a registration under ATC M03AC10 (mivacurium chloride), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose

Mivacurium chloride · ATC M03AC10

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
The Wellcome Foundation Limited
Country
Finland (FI)
ATC code
M03AC10
ATC class
Mivacurium chloride
Defined daily dose
14 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

76 interactions on record for mivacurium chloride.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Mivacurium chloride · interactions on record

76 records

  • 12 severe
  • 60 moderate
  • 4 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dfeead63-5c93-483e-912b-8aa1271f0387
GET /v1/drugs/dfeead63-5c93-483e-912b-8aa1271f0387?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste",
  "route": null,
  "ddd_unit": null,
  "strength": "2 mg/ml",
  "atc_label": "mivakuriumkloridi",
  "ma_number": "11507",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL4813",
  "authorised_at": "1994-06-20"
}

See everything about mivacurium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.